Myriad Genetics, Inc. Provides Financial Guidance for 2023 and 2024
Myriad Genetics introduces its 2024 revenue guidance of between $815 million and $835 million, or 9% - 11% growth over the mid-point of the 2023 revenue guidance range.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.26 USD | +1.93% |
|
+4.57% | +26.75% |
1st Jan change | Capi. | |
---|---|---|
+26.75% | 2.2B | |
-11.68% | 11.22B | |
-10.38% | 7.58B | |
+27.58% | 5.48B | |
+1.44% | 5.38B | |
-17.38% | 3.77B | |
+8.12% | 2.6B | |
-64.90% | 2.35B | |
-10.17% | 2.25B | |
-12.53% | 1.7B |